Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on UDCA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover the enzymatic synthesis of 3 beta 7 beta dihydroxy 5 alpha H UDCA isomer. A cost-effective, high-purity pharmaceutical intermediate solution.
Patent CN113736842B reveals high-purity TUDCA production via multi-cell catalysis. Offers cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN106701882A details a novel chemo-enzymatic route for UDCA production offering high purity and scalable manufacturing capabilities for global pharmaceutical supply chains.
Patent CN114940964B reveals efficient UDCA production. Reduced costs and high purity for pharmaceutical supply chains.